PL354958A1 - Kompozycja farmaceutyczna w postaci szybko dyspergującej się dawki zawierającej nośnik żelatynowy - Google Patents
Kompozycja farmaceutyczna w postaci szybko dyspergującej się dawki zawierającej nośnik żelatynowyInfo
- Publication number
- PL354958A1 PL354958A1 PL00354958A PL35495800A PL354958A1 PL 354958 A1 PL354958 A1 PL 354958A1 PL 00354958 A PL00354958 A PL 00354958A PL 35495800 A PL35495800 A PL 35495800A PL 354958 A1 PL354958 A1 PL 354958A1
- Authority
- PL
- Poland
- Prior art keywords
- fast
- fish gelatin
- dispersing dosage
- composition
- dosage forms
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title abstract 5
- 108010010803 Gelatin Proteins 0.000 title abstract 4
- 229920000159 gelatin Polymers 0.000 title abstract 4
- 239000008273 gelatin Substances 0.000 title abstract 4
- 235000019322 gelatine Nutrition 0.000 title abstract 4
- 235000011852 gelatine desserts Nutrition 0.000 title abstract 4
- 239000002552 dosage form Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000012530 fluid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9908014.5A GB9908014D0 (en) | 1999-04-08 | 1999-04-08 | Pharmaceutical compositions |
| PCT/US2000/009278 WO2000061117A1 (en) | 1999-04-08 | 2000-04-07 | Fast-dispersing dosage forms containing fish gelatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL354958A1 true PL354958A1 (pl) | 2004-03-22 |
| PL196572B1 PL196572B1 (pl) | 2008-01-31 |
Family
ID=10851154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL354958A PL196572B1 (pl) | 1999-04-08 | 2000-04-07 | Kompozycja farmaceutyczna w postaci szybko dyspergującej się dawki zawierającej nośnik żelatynowy |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US6709669B1 (pl) |
| EP (1) | EP1165053B1 (pl) |
| JP (1) | JP4838939B2 (pl) |
| KR (1) | KR100767076B1 (pl) |
| CN (1) | CN1224381C (pl) |
| AT (1) | ATE262890T1 (pl) |
| AU (1) | AU761439B2 (pl) |
| BR (1) | BR0009609A (pl) |
| CA (1) | CA2369715C (pl) |
| CZ (1) | CZ295324B6 (pl) |
| DE (1) | DE60009472T2 (pl) |
| DK (1) | DK1165053T3 (pl) |
| ES (1) | ES2215645T3 (pl) |
| GB (1) | GB9908014D0 (pl) |
| HK (1) | HK1039066B (pl) |
| HU (1) | HU229892B1 (pl) |
| IL (2) | IL145783A0 (pl) |
| IS (1) | IS2403B (pl) |
| MX (1) | MXPA01010094A (pl) |
| NO (1) | NO330196B1 (pl) |
| NZ (1) | NZ515230A (pl) |
| PL (1) | PL196572B1 (pl) |
| PT (1) | PT1165053E (pl) |
| RO (1) | RO122011B1 (pl) |
| RU (1) | RU2242969C2 (pl) |
| TR (1) | TR200102881T2 (pl) |
| WO (1) | WO2000061117A1 (pl) |
| ZA (1) | ZA200109089B (pl) |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040023948A1 (en) * | 1997-03-24 | 2004-02-05 | Green Richard David | Fast-dispersing dosage form containing 5-HT1 agonists |
| GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| GB9910505D0 (en) * | 1999-05-06 | 1999-07-07 | Electrosols Ltd | A method and apparatus for manufacturing consumable tablets |
| EP1238675A1 (en) * | 2001-03-06 | 2002-09-11 | Fuji Photo Film B.V. | Recombinant gelatin-like proteins for use as plasma expanders |
| ITRM20010380A1 (it) * | 2001-07-02 | 2003-01-02 | Bioprogress Spa | Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso. |
| DE60200861T2 (de) * | 2001-07-02 | 2005-08-04 | Bioprogress S.P.A. | Verwendungen einer Zusammensetzung enthaltend teilweise hydrolysiertes Fischgelatin |
| KR100425226B1 (ko) * | 2001-07-03 | 2004-03-30 | 주식회사 팜트리 | 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법 |
| GB0125061D0 (en) * | 2001-10-18 | 2001-12-12 | Norton Healthcare Ltd | Pharmaceutical composition |
| GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| DE60307082D1 (de) * | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
| GB0226076D0 (en) * | 2002-11-08 | 2002-12-18 | Rp Scherer Technologies Inc | Improved formulations containing substituted imidazole derivatives |
| RU2372074C2 (ru) * | 2002-11-26 | 2009-11-10 | Альк-Абелло А/С | Лекарственная форма, содержащая аллерген |
| WO2004047793A1 (en) * | 2002-11-26 | 2004-06-10 | Alk-Abelló A/S | Pharmaceutical allergen product |
| UA93479C2 (en) * | 2002-11-26 | 2011-02-25 | Альк-Абелло A/C | Allergen dosage form |
| US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
| CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| WO2005046707A1 (en) | 2003-11-10 | 2005-05-26 | Fein Seymour H | Pharmaceutical compositions including low dosages of desmopressin |
| DE20321887U1 (de) | 2003-11-10 | 2012-01-20 | Allergan, Inc. | Arzneimittel umfassend niedrige Dosierungen von Desmopressin |
| PT1530967E (pt) | 2003-11-13 | 2006-09-29 | Ferring Bv | Embalagem blister e uma forma de dosagem solida que compreende desmopressina. |
| US9241902B2 (en) | 2003-12-17 | 2016-01-26 | R.P. Scherer Technologies, Llc | Chewable soft capsules containing ungelatinized starch |
| US7972621B2 (en) * | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| EP1817009A2 (en) * | 2004-11-24 | 2007-08-15 | Spi Pharma, Inc. | Orally disintegrating compositions |
| BRPI0519212A2 (pt) * | 2004-12-23 | 2009-01-06 | Mcneil Ppc Inc | composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial |
| US20060210590A1 (en) | 2005-02-03 | 2006-09-21 | Alk-Abello A/S | Minor allergen control to increase safety of immunotherapy |
| GB0510286D0 (en) * | 2005-05-19 | 2005-06-29 | Kilda Biolink As | Composition |
| WO2006123173A1 (en) * | 2005-05-19 | 2006-11-23 | Kilda Biolink As | Gelatin-containing topical composition |
| RU2370268C2 (ru) * | 2005-05-25 | 2009-10-20 | Лабораториос Баго С.А. | Способ получения фармацевтической композиции для орального введения, обладающей улучшенной биодоступностью биологически активного действующего лекарственного вещества, и фармацевтическая композиция, полученная этим способом |
| TW200816985A (en) * | 2006-06-05 | 2008-04-16 | Verus Pharmaceuticals Inc | Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies |
| US20070293582A1 (en) * | 2006-06-05 | 2007-12-20 | Malcolm Hill | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
| EP2043613A1 (en) * | 2006-07-14 | 2009-04-08 | Fmc Corporation | Solid form |
| TWI343262B (en) * | 2006-09-26 | 2011-06-11 | Schering Corp | Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| US20090214442A1 (en) * | 2006-12-01 | 2009-08-27 | Cephalon, Inc. | Oral Transmucosal Nicotine Dosage Form |
| BRPI0719428A2 (pt) * | 2006-12-01 | 2014-02-25 | Cima Labs Inc | Forma de dosagem transmucosal oral sólida, método para tratar dependência de nicotina em um receptor que deseja tal tratamento, sistema de distribuição de nicotina transmucosal oral, e, método de substituíção de nicotina. |
| US20080311162A1 (en) * | 2007-05-16 | 2008-12-18 | Olivia Darmuzey | Solid form |
| WO2008150526A1 (en) * | 2007-06-04 | 2008-12-11 | Shear/Kershman Laboratories, Inc. | Tamper resistant lipid-based oral dosage form for opioid agonists |
| US20090004231A1 (en) | 2007-06-30 | 2009-01-01 | Popp Shane M | Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring |
| KR100905027B1 (ko) * | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | 식용 필름 |
| GB2453770A (en) * | 2007-10-19 | 2009-04-22 | Reckitt Benckiser Healthcare | Oral composition comprising a cooling agent |
| ES2633928T3 (es) * | 2008-02-28 | 2017-09-26 | R.P. Scherer Technologies, Llc | Proceso para minimizar polimorfismo |
| NO3085381T3 (pl) | 2008-05-21 | 2018-09-15 | ||
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| US8420700B1 (en) * | 2008-06-04 | 2013-04-16 | James M. Bausch | Tamper resistant lipid-based oral dosage form for sympathomimetic amines |
| JP5785077B2 (ja) * | 2008-08-05 | 2015-09-24 | ワイス・エルエルシー | 崩壊温度より高温での凍結乾燥 |
| JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
| TWI471127B (zh) | 2009-04-29 | 2015-02-01 | Intervet Int Bv | 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物 |
| CA2765221C (en) | 2009-06-18 | 2017-10-03 | Allergan, Inc. | Safe desmopressin administration |
| WO2011026080A1 (en) * | 2009-08-31 | 2011-03-03 | Wilmington Pharmaceuticals, Llc | Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain |
| US9775819B2 (en) * | 2009-09-16 | 2017-10-03 | R.P. Scherer Technologies, Llc | Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
| WO2011053251A1 (en) | 2009-10-30 | 2011-05-05 | Ix Biopharma Pte Ltd | Fast dissolving solid dosage form |
| US10548839B2 (en) * | 2010-03-16 | 2020-02-04 | Wei Tian | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| BR112012024432A2 (pt) | 2010-03-29 | 2016-05-31 | Ferring Bv | composição farmacêutica de dissolução rápida |
| JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
| BR112013009255B1 (pt) * | 2010-10-08 | 2021-02-23 | R.P. Scherer Technologies, Llc | composição sólida de vacina oral de dissolução rápida |
| JP2012121850A (ja) * | 2010-12-09 | 2012-06-28 | Otsuka Pharmaceut Co Ltd | アリピプラゾールの経口速溶性組成物 |
| WO2012106058A2 (en) | 2011-01-31 | 2012-08-09 | New Market Pharmaceuticals | Animal treatments |
| JP2011116764A (ja) * | 2011-02-08 | 2011-06-16 | Fine Seymour H | 低用量デスモプレシンを含有する医薬組成物 |
| JP6174585B2 (ja) | 2011-09-16 | 2017-08-02 | フェリング ベスローテン フェンノートシャップ | 速溶性医薬組成物 |
| EP3505159B1 (en) | 2012-05-02 | 2020-11-04 | NewMarket Pharmaceuticals LLC | Pharmaceutical compositions for direct systemic introduction |
| TW201422254A (zh) | 2012-11-21 | 2014-06-16 | Ferring Bv | 用於速釋及延釋的組成物 |
| JP2015172084A (ja) * | 2015-07-06 | 2015-10-01 | 大塚製薬株式会社 | アリピプラゾールの経口速溶性組成物 |
| CN107397208B (zh) * | 2016-07-20 | 2021-05-07 | 吴登成 | 以鱼鳔胶为主成分的功能食品及其用途 |
| CA3040422A1 (en) * | 2016-10-13 | 2018-04-19 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
| US11517533B2 (en) | 2016-10-25 | 2022-12-06 | Catalent U.K. Swindon Zydis Limited | Compositions of different densities for fast disintegrating multi-layer tablet |
| IL267689B2 (en) | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| AU2018208531A1 (en) | 2017-01-11 | 2019-06-13 | Ferring B.V. | A fast disintegrating pharmaceutical composition |
| DE102017104472A1 (de) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung |
| US10517834B2 (en) * | 2017-05-16 | 2019-12-31 | Owen Murray | Fast dissolving tablet formulations and methods of making thereof |
| CN110944641A (zh) * | 2017-06-20 | 2020-03-31 | 西雅图咖米公司 | 明胶胶粘组合物及其制造和使用方法 |
| PT3706739T (pt) | 2017-11-12 | 2024-12-04 | Biohaven Therapeutics Ltd | Utilização de profármacos de riluzol para tratar ataxias |
| EP3761956B1 (en) | 2018-03-08 | 2024-06-12 | Catalent U.K. Swindon Zydis Limited | Process to reduce endotoxin in gelatin |
| DK4088720T3 (da) * | 2018-03-25 | 2025-09-29 | Pfizer Ireland Pharmaceuticals Unlimited Company | Rimegepant til cgrp-relaterede lidelser |
| CN112203692A (zh) * | 2018-05-27 | 2021-01-08 | 拜尔哈文制药股份有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
| IL279713B2 (en) | 2018-06-27 | 2025-01-01 | Bioxcel Therapeutics Inc | Dexmedetomidine-containing layer compositions and methods for their production |
| CN112584831A (zh) * | 2018-08-16 | 2021-03-30 | 拜奥海芬治疗学有限公司 | 利鲁唑口腔崩解片用于治疗疾病的用途 |
| KR20210116560A (ko) * | 2019-01-20 | 2021-09-27 | 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. | 편두통 돌발을 치료하기 위한 cgrp 길항제 |
| AR118418A1 (es) | 2019-02-22 | 2021-10-06 | Catalent Uk Swindon Zydis Ltd | Conservación de partículas ifa revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspensión acuosa |
| BR112021016485A2 (pt) | 2019-02-22 | 2021-10-13 | Catalent U.K. Swindon Zydis Limited | Minimização de aglomeração de material de revestimento de partícula de fármaco durante armazenamento para estabilizar tempos de desintegração de produtos farmacêuticos |
| CN113490486B (zh) | 2019-02-22 | 2025-10-17 | 康特伦英国斯温顿捷迪斯有限公司 | 最小化团聚、曝气和保持包含布洛芬的药物组合物的包衣 |
| CA3129383A1 (en) | 2019-02-22 | 2020-08-27 | Catalent U.K. Swindon Zydis Limited | Minimizing aeration of suspensions during in-line mixing |
| EP3999058A4 (en) | 2019-07-19 | 2023-05-03 | Bioxcel Therapeutics, Inc. | TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN |
| WO2021132741A1 (ko) * | 2019-12-23 | 2021-07-01 | 주식회사 피엘마이크로메드 | 색전 시술 입자 및 이의 제조방법 |
| MX2023001004A (es) | 2020-07-31 | 2023-03-01 | Catalent Uk Swindon Zydis Ltd | Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto. |
| MX2023002660A (es) | 2020-09-17 | 2023-03-28 | Catalent Uk Swindon Zydis Ltd | Uso de tensioactivo con formulaciones de dosificacion a base de gelatina de pescado de alto peso molecular para mejorar caracteristicas de flujo. |
| AU2021351921A1 (en) | 2020-09-29 | 2023-04-06 | Millicent Pharma Limited | Orodispersible formulations |
| LT4243797T (lt) * | 2020-11-16 | 2026-06-10 | Orcosa Inc. | Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui |
| US11672761B2 (en) * | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| WO2022155564A1 (en) | 2021-01-18 | 2022-07-21 | Biohaven Therapeutics Ltd. | Use of riluzole prodrugs to treat alzheimer's disease |
| WO2022179635A1 (zh) * | 2021-02-27 | 2022-09-01 | 北京兴源联合医药科技有限公司 | 一种β-烟酰胺单核苷酸冻干口服制剂 |
| EP4329759A4 (en) | 2021-04-30 | 2025-07-16 | Mind Medicine Inc | CRYSTALLINE FORMS OF LSD SALTS |
| BR112023025552A2 (pt) * | 2021-06-11 | 2024-02-27 | Orphai Therapeutics Inc | Composições estabilizadas de apilimod e usos das mesmas |
| US20230064429A1 (en) * | 2021-08-19 | 2023-03-02 | Mind Medicine, Inc. | IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
| WO2025034773A1 (en) * | 2023-08-07 | 2025-02-13 | Biohaven Therapeutics Ltd. | Trpm3 modulators for treatment of pain |
| WO2025064381A1 (en) * | 2023-09-18 | 2025-03-27 | Phathom Pharmaceuticals Inc. | Method for preparing vonoprazan with reduced nitrosamine |
| WO2025224601A1 (en) | 2024-04-21 | 2025-10-30 | Biohaven Therapeutics Ltd. | Trpm3 antagonists for the treatment of migraine and pain |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2246013A1 (de) | 1972-09-20 | 1974-03-28 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von poroesen tabletten |
| DE2556561C2 (de) | 1975-12-16 | 1983-04-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur Herstellung von porösen Tabletten |
| GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
| US4139497A (en) * | 1977-04-04 | 1979-02-13 | The Dow Chemical Company | Dehydrogenation catalyst tablet and method for making same |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| US4762719A (en) * | 1986-08-07 | 1988-08-09 | Mark Forester | Powder filled cough product |
| US5035896A (en) * | 1988-06-15 | 1991-07-30 | Warner-Lambert Company | Water insoluble drugs coated by coacervated fish gelatin |
| MC2034A1 (fr) | 1988-06-23 | 1990-05-30 | Hoffmann La Roche | Preparations |
| IL87344A (en) | 1988-08-04 | 1992-03-29 | Univ Bar Ilan | Process for the production of gelatin from fish skins |
| US4935243A (en) | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
| US4946684A (en) | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
| US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
| EP0737473A1 (en) | 1989-10-02 | 1996-10-16 | Cima Labs, Inc. | Effervescent dosage form |
| EP0542914A4 (en) | 1990-08-10 | 1993-11-18 | Analytical Control Systems, Inc. | Improved diagnostic and therapeutic compositions |
| FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
| CA2120701A1 (en) * | 1991-10-11 | 1993-04-15 | Sharon M. Devereaux | Unit-of-use reagent composition for specific binding assays |
| RU2109509C1 (ru) | 1991-12-24 | 1998-04-27 | Яманути Фармасьютикал Ко., Лтд. | Композиция для буккального введения лекарственного средства и способ ее получения |
| CA2117351C (en) | 1992-01-13 | 1998-03-03 | Julian Belknap Lo | Preparation of tablets of increased strength |
| US5298261A (en) | 1992-04-20 | 1994-03-29 | Oregon Freeze Dry, Inc. | Rapidly distintegrating tablet |
| FR2702968B1 (fr) | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
| ATE208615T1 (de) * | 1993-07-09 | 2001-11-15 | Scherer Corp R P | Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen |
| US5382437A (en) | 1993-10-25 | 1995-01-17 | Hunter Research Corporation | Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
| US5595761A (en) * | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
| US5484888A (en) | 1994-03-08 | 1996-01-16 | Holzer; David | Gelatin production |
| US5603952A (en) * | 1994-12-30 | 1997-02-18 | Tastemaker | Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom |
| GB9517062D0 (en) | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
| WO1997038679A2 (en) | 1996-04-16 | 1997-10-23 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
| US5879796A (en) * | 1996-09-05 | 1999-03-09 | E. I. Du Pont De Nemours And Company | Organic/inorganic particulates |
| US6071963A (en) | 1996-11-06 | 2000-06-06 | Roche Vitamins Inc. | Water dispersible compositions |
| PL336007A1 (en) * | 1997-04-03 | 2000-06-05 | Bridge Pharma | Chemical compounds of benzocycloheptathiophene |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| US6077540A (en) | 1997-08-08 | 2000-06-20 | Bayer Corporation | Gelatin spray coating |
| US6020003A (en) * | 1998-02-23 | 2000-02-01 | Basf Corporation | Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin |
| GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
| US6284270B1 (en) * | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
| US7972621B2 (en) | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
-
1999
- 1999-04-08 GB GBGB9908014.5A patent/GB9908014D0/en not_active Ceased
-
2000
- 2000-04-07 IL IL14578300A patent/IL145783A0/xx active IP Right Grant
- 2000-04-07 AU AU43331/00A patent/AU761439B2/en not_active Expired
- 2000-04-07 HU HU0201877A patent/HU229892B1/hu active IP Right Revival
- 2000-04-07 ES ES00923161T patent/ES2215645T3/es not_active Expired - Lifetime
- 2000-04-07 DE DE60009472T patent/DE60009472T2/de not_active Expired - Lifetime
- 2000-04-07 PL PL354958A patent/PL196572B1/pl unknown
- 2000-04-07 CN CNB008073090A patent/CN1224381C/zh not_active Expired - Lifetime
- 2000-04-07 CZ CZ20013588A patent/CZ295324B6/cs not_active IP Right Cessation
- 2000-04-07 JP JP2000610450A patent/JP4838939B2/ja not_active Expired - Lifetime
- 2000-04-07 DK DK00923161T patent/DK1165053T3/da active
- 2000-04-07 PT PT00923161T patent/PT1165053E/pt unknown
- 2000-04-07 WO PCT/US2000/009278 patent/WO2000061117A1/en not_active Ceased
- 2000-04-07 BR BR0009609-1A patent/BR0009609A/pt not_active Application Discontinuation
- 2000-04-07 TR TR2001/02881T patent/TR200102881T2/xx unknown
- 2000-04-07 CA CA002369715A patent/CA2369715C/en not_active Expired - Lifetime
- 2000-04-07 NZ NZ515230A patent/NZ515230A/xx not_active IP Right Cessation
- 2000-04-07 HK HK02100499.4A patent/HK1039066B/en not_active IP Right Cessation
- 2000-04-07 RO ROA200101104A patent/RO122011B1/ro unknown
- 2000-04-07 KR KR1020017012767A patent/KR100767076B1/ko not_active Expired - Lifetime
- 2000-04-07 US US09/959,018 patent/US6709669B1/en not_active Expired - Lifetime
- 2000-04-07 RU RU2001130047/15A patent/RU2242969C2/ru active
- 2000-04-07 AT AT00923161T patent/ATE262890T1/de active
- 2000-04-07 EP EP00923161A patent/EP1165053B1/en not_active Expired - Lifetime
- 2000-04-07 MX MXPA01010094A patent/MXPA01010094A/es active IP Right Grant
-
2001
- 2001-10-04 IS IS6102A patent/IS2403B/is unknown
- 2001-10-04 IL IL145783A patent/IL145783A/en not_active IP Right Cessation
- 2001-10-05 NO NO20014859A patent/NO330196B1/no not_active IP Right Cessation
- 2001-11-02 ZA ZA200109089A patent/ZA200109089B/xx unknown
-
2003
- 2003-10-14 US US10/685,728 patent/US9192580B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145783A0 (en) | Fast-dispersing dosage forms containing fish gelatin | |
| YU33099A (sh) | Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca | |
| TWI235068B (en) | Sustained-release pharmaceutical composition | |
| IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| ATE340563T1 (de) | DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT | |
| DE69940674D1 (de) | Orale verabreichung von adenosin analogen | |
| UA41995C2 (uk) | Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти ) | |
| UA42061C2 (uk) | Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса | |
| AU1227899A (en) | Osmotic medicament releasing system | |
| ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| HRP20010684B1 (hr) | Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina | |
| ES2130081A1 (es) | Comprimido de maleato de trimebutina con recubrimiento laminar. | |
| SE9700885D0 (sv) | New pharmaceutical formulation | |
| TW200505436A (en) | Modified release pharmaceutical compositions and the processes for preparing them | |
| BG101080A (en) | Medicamentous form of carbamasepin with delayed release of the active substance | |
| SG145717A1 (en) | Composition for releasing a weak base for an extended period of time | |
| AP1736A (en) | Oral dosage form for controlled drug release. | |
| MX9606041A (es) | Forma de dosificacion de rapida disolucion. |